New Journey Health Technology Group Co (SZSE:002219) LT-Debt-to-Total-Asset : 0.09 (As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is New Journey Health Technology Group Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. New Journey Health Technology Group Co's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.09.

New Journey Health Technology Group Co's long-term debt to total assets ratio declined from Jun. 2023 (0.13) to Jun. 2024 (0.09). It may suggest that New Journey Health Technology Group Co is progressively becoming less dependent on debt to grow their business.

New Journey Health Technology Group Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for New Journey Health Technology Group Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Journey Health Technology Group Co LT-Debt-to-Total-Asset Chart

New Journey Health Technology Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.06

0.05

0.08

0.13

New Journey Health Technology Group Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.13	0.13	0.13	0.12	0.09

New Journey Health Technology Group Co LT-Debt-to-Total-Asset Calculation

New Journey Health Technology Group Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	796.942	/	6080.205
	=	0.13

New Journey Health Technology Group Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )	/	Total Assets (Q: Jun. 2024 )
	=	568.667	/	6304.292
	=	0.09

New Journey Health Technology Group Co (SZSE:002219) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

New Journey Health Technology Group Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of New Journey Health Technology Group Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

New Journey Health Technology Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » New Journey Health Technology Group Co Ltd (SZSE:002219) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

Duyiyi Industrial Park, Wangba, Kang County, Gansu Province, Longnan, CHN, 610000

Website

http://www.hkmg.com

New Journey Health Technology Group Co Ltd formerly Hengkang Medical Group Co Ltd is engaged in research, development, and manufacturing of natural herbal medicines. The company's products include analgesic and haemostatic drugs.

Executives

Song Li Hua	Directors, executives
Yu Mei	Directors, executives
Wang Yong	Executives
Zuo Bin Lin	Executives
Tang Can	Director
Duan Zhi Ping	Director
Zhou Xian Min	Director
Guo Kai	Executives

Xie Hai	Executives
Shi Xiao Ming	Executives
Li Yu Fei	Supervisors
Huang Rui	Directors, executives
Pan Yu	Supervisors
Liao Li Dong	Executives

New Journey Health Technology Group Co Headlines

No Headlines